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7CASE REPORT Open AccessThe riddle of multinucleated “floret-like” giant
cells and their detection in an extensive gluteal
neurofibroma: a case report
Katrin Stanger1,2,4*, Sora De Kerviler1, Istvan Vajtai3 and Mihai Constantinescu1,2Abstract
Introduction: The neurofibromatoses are inherited tumor predisposition syndromes involving two major clinical
phenotypes: neurofibromatosis type 1 (von Recklinghausen's disease) is linked to chromosome 17q, and tends to
occur seven times more frequently than neurofibromatosis type 2. Neurofibromatosis type 1 entails a distinctive
cutaneous manifestation prevailed upon by benign neurofibromas, which may vary in size, number and distribution.
On the histological level, neurofibromas are composed of an admixture of neurilemmal cells, including Schwann
cells, fibroblasts, and – to a lesser extent – perineurial cells.
Case presentation: The case of a 39-year-old Caucasian man with a voluminous recurrent neurofibroma of
27×15cm extending from the left gluteal region to thoraco-lumbar levels Th6 through L4 is reported. Within the
soft tissue tumor a pseudocyst of 7.3×9.3cm was found preoperatively.
Conclusion: Histopathological study of the excised mass was conspicuous for revealing a large number of
multinucleated floret-like giant cells within an otherwise classical soft tissue neurofibroma.
Previous reports on neurofibromas with multinucleated floret-like giant cells are distinctly scant. Available evidence
from the literature does not suggest any consistent correlation of multinucleated floret-like giant cells in
neurofibromas with gender, age, traumatic antecedents, size of the lesion, recurrence, or malignant transformation.
Furthermore, the presence of such cells may not be specific for neurofibromatosis type 1, as they occasionally are
encountered in some unrelated mesenchymal neoplasms as well.
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Neurofibromatosis type 1 (NF1) is a dysgenetic complex
which is due to a loss of function of the tumor-suppressor
gene product neurofibromin located on chromosome 17q
[1]. Mutations therefor exert a pleiotropic effect on deriva-
tives of the neural crest including embryonic misplacement
and deregulated proliferation of Schwann cells, perineural
cells, and melanocytes [2]. The condition is autosomal
dominant with variable penetrance and exhibits a high de-
gree of de novo mutations [3]. NF1 exhibits a conspicuous
cutaneous phenotype including benign neurofibromas,
hyperpigmented macules ("café au lait" spots), axillary and* Correspondence: km@stangermail.de
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reproduction in any medium, provided the oringuinal freckling, as well as pigmented hamartomas of the
iris (Lisch nodules), and distinctive osseous lesions [4,5].
Variable in number and distribution, neurofibromas are
painless, slow-growing tumors. Their transformation into
malignant peripheral nerve sheath tumors will occur in ap-
proximately 7 to 13% of the affected individuals [6,7]. Most
of these malignant tumors tend to evolve from plexiform
lesions, males being at a higher risk for such evolution [5].
Early diagnosis based on the clinical phenotype, genetic
counseling, treatment of symptoms, and appropriate sur-
geries are the tools available for management of patients
with NF1 [3]. Surgical procedures generally involve re-
section, combined with reconstructive strategies aimed
at functional and aesthetic improvement [8]. Although
the majority of neurofibromas can be excised com-
pletely by a subcutaneous approach, and closed primar-
ily, surgery of extensive neurofibromas (massive softl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A: Preoperative findings of the gluteal soft tissue
tumor. B: Postoperative results at 7 weeks.
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high vascularity [3,8-10].
Although the histological identification of the NF1-
associated neurofibromas is rather straightforward in prac-
tical terms, these tumors are notorious for exhibiting
microscopic details that are apt to confound correct mor-
phological diagnosis in an individual. The presence of so-
called floret-like multinucleated giant cells (FMGCs) is
one such detail [11].
We describe an intriguing case of an extensive lumbar
and gluteal neurofibroma with FMGCs in a patient with
NF1 and review the literature to investigate the associ-
ation of FMGCs with NF1.
Case presentation
A 39-year-old man of Caucasian descent with a positive
family history for NF1 disease had been diagnosed with
NF1 at the age of 10 years. Two years later he under-
went resection of spinal and radicular neurofibromas
with stabilization of the vertebral column. He presented
at our out-patient service 27 years later with a recurrent
soft tissue mass involving the left gluteal region along
with paravertebral extension to Th6 through L4. The
paravertebral and gluteal finding on the left side was
a soft tissue tumor measuring 27×15cm, whereas
the paravertebral tumor on the right side measured
10×13cm. The gluteal mass entailed ptosis and bulging
(Figure 1A). Within the paravertebral moiety, a cyst-like
fluctuation of 8×8cm was palpable. No pain, swelling or
eczema was noted but enlargement of the paravertebral
soft tissue tumor could be elicited by pressing. Further-
more, subcutaneous papulonodular indurations were palp-
able. The patient was heavily impaired by the tumor while
sitting or performing physical activity, and reported on be-
ing distressed by the cosmetic deformity. Pressure on the
tumor provoked sharp pain. After a history of multiple re-
sections of several smaller neurofibromas, the tumor now
showed a quick progression during one month. In
addition, he developed multiple "café au lait" spots on his
back, and bilateral gluteal freckling as well as multiple
small neurofibromas on his trunk and both thighs. On his
left forehead, a neurofibroma of 3×1.5cm was present.
Lisch nodules without retinopathy were observed in
both eyes.
An abdominal-pelvic computed tomography scan re-
vealed an extensive mass lesion displacing the soft tissue of
the left gluteal region and a fluid-filled vertebral cystic cav-
ity of 8.3×20.3cm (Figures 2 and 3). Although no subcuta-
neous connection between the paravertebral and gluteal
findings was demonstrated, the consulting neurosurgeon
advised against the resection of what was interpreted to
represent a meningocele.
The patient underwent wide partial excision (20×12cm)
of the neurofibroma under general anesthesia. Because ofthe presence of irregular frail and plexus-like veins, sub-
tle hemostasis was mandatory throughout the proced-
ure. Direct wound closure could be achieved by
advancement and rotation of the adjacent skin. Seven
weeks following surgery, there was significant reduction
of the left paravertebral and gluteal bulging, and an im-
proved symmetry of the lumbar and gluteal regions
(Figure 1B). The patient also reported a reduction in the
Figure 2 Fluid-filled vertebral cystic cavity of 8.3×20.3cm
representing a meningocele.
Stanger et al. Journal of Medical Case Reports 2013, 7:189 Page 3 of 6
http://www.jmedicalcasereports.com/content/7/1/189localized pain he had experienced prior to resection and
remained satisfied at 1 year follow-up, with no recur-
rence of the neurofibromatous mass.
Following overnight fixation in 10% buffered formalin,
the resection specimen was routinely processed to paraffin,
and 3μm-thick slides were stained with hematoxylin and
eosin for microscopic study. Immunohistochemistry was
performed with the following panel of antibodies: vimentin
(clone Vim 3B4; Dako, Glostrup, Denmark), CD34 (clone
QBend/10; Dako), S100 protein (polyclonal; Dako), smooth
muscle actin (clone 1A4; Sigma, St. Louis, MO, United
States of America), epithelial membrane antigen (EMA;
clone E29; Dako), glucose transporter 1 (GLUT-1; poly-
clonal; Abcam, Cambridge, United Kingdom), according toFigure 3 Fluid-filled vertebral cystic cavity of 8.3×20.3cm
representing a meningocele.established protocols in our laboratory. Slides were devel-
oped with polymer-bound horseradish peroxidase (Envi-
sion+; Dako) and 3,3'-diaminobenzidine as chromogen.
Microscopic examination of the surgical specimen
showed a plaque-like proliferation of spindle cells with
wavy bipolar cytoplasm and mostly cigar-shaped nuclei,
diffusely involving the entire breadth of the dermis
(Figure 4A), and focally encroaching upon the subcuta-
neous fat (Figure 4B). Although there was neither sig-
nificant nuclear atypia nor any diagnostically relevant
mitotic activity, the tumor was conspicuous for includ-
ing several aggregates of multinucleated giant cells with
star-shaped cytoplasmatic projections corresponding to
floret-like cells (Figure 4C, D). Furthermore, some areas
of Meissner-like differentiation were seen (Figure 4D).
Although an occasional peripheral nerve fascicle was felt
to contain neurofibroma cells within the endoneurium
(Figure 4E), no bona fide plexiform component was
detected. The immunophenotype of the FMGCs included
positivity for vimentin and CD34 (Figure 5A, B); whereas
no staining was observed for S100 protein, SMA, EMA,
and GLUT-1, respectively.
Discussion
The etiology of FMGCs is unknown [11,12]. We are aware
of only four previous case reports on FMGCs in neuro-
fibromas arising in the setting of NF1 [5,13-15], as well as
a recently published single retrospective clinicopathologic
study of 22 patients with NF1 and FMGCs [11]. Magro et
al. raise the question whether this phenomenon is merely
an uncommon incidental finding or if it is pathognomonic
for NF1 [11,12,14]. These authors suggest that FMGCs in
an otherwise typical neurofibroma may not be indicators
of NF1, but more probably represent reactive change of
the indigenous dermal or endoneurial fibroblasts or den-
dritic cells in response to some unknown microenviron-
mental stimulus [11]. In their series of 94 neurofibromas,
only 23% of the cases contained FMGCs, in 17 of these
cases FMGCs cells were only identified after meticulous
search. Only in 5% of the series were FMGCs found to be
numerous and readily identifiable. With regard to clinical
features, no correlation was found between FMGCs and
gender (p=0.59) or age (<45 versus ≥45; p=0.43) [11].
Interestingly, FMGCs have also been detected in other
tissues, including breast tissue in gynecomastia [13,16].
They were further described in uncommon soft tissue
tumors including pleomorphic lipoma, giant cell co-
llagenoma, giant cell fibroblastoma and giant cell an-
giofibroma, pseudoangiomatous stromal hyperplasia of the
male breast in NF1, as well as in a breast hamartoma from
a 6-year-old boy with NF1 and in a 50-year-old woman
without any signs of NF1 [12,14,16,17].
Swick [15] concluded that FMGCs in neurofibromas
should not be misinterpreted as harbingers of malignant
Figure 4 Microscopic aspect of neurofibroma with floret-like cells. A Overview to show diffuse infiltration of reticular dermis by neurofibroma,
wherein cutaneous appendages (eccrine glands) appear permeated rather than dislocated by tumor cells. B Along the border to subcutaneous fat,
neurofibroma cells tend to gradually merge with local adipocytes. C The cellular monotony of underlying neurofibroma is focally disrupted by large
multinucleated cells (floret-like cells; arrows). These were felt to occur in a haphazard manner irrespective of local variation in tumor architecture.
D High magnification view to show cytologic detail of two floret-like giant cells. Peripheral crowding of multiple nuclei along jagged cytoplasmic
borders is appreciated in floret-like cell on center left. E Meissnerian-like differentiation is particularly frequent in – if not characteristic of – syndrome-
associated neurofibromas. F An occasional tortuous peripheral nerve fascicle expanded by endoneurial tumor cells is felt to represent an elementary
form of plexiform neurofibroma. All microphotographs represent slides stained by hematoxylin and eosin. Original magnifications: A – ×40; B, C,
F – ×100; D – ×400; E – ×200.
Figure 5 Immunophenotype of floret-like giant cells within neurofibromatosis type 1-associated cutaneous neurofibroma. (A) Most
floret-like giant cells (arrows) exhibited intense cytoplasmic staining with the generic mesenchymal intermediate filament protein vimentin, and
(B) shared immunoreactivity for the myofibroblastic marker CD34 (arrows) with gracile endoneurial-type fibroblasts (arrowheads) that tend to
ubiquitously occur within neurofibromas. (C) Whereas the main population of neurofibroma tumor cells is positive for S100 protein (arrowheads),
floret-like giant cells (arrows) are not. Further, consistently negative reactions included (D) smooth muscular actin (arrows), as well as the
perineurial markers (E) EMA (epithelial membrane antigen) (arrows), and (F) GLUT-1 (glucose transporter 1) (arrow). Original magnification:
(A) through (F) ×200.
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tion of non–Schwannian S100 protein- and CD34+ posi-
tive cells similar to CD34-positive endoneurial dendritic
cells found in normal nerves and neurofibromas. Negativ-
ity of these cells for S100 protein combined with the ab-
sence of either cytologic atypia or mitoses assist in ruling
out actual malignant transformation. FMGCs are also seen
in other soft tissue tumors “not” associated with NF1: the
presence of FMGCs in these neoplasms support the hy-
pothesis that FMGCs are not specific to neurofibromas or
to hyperplastic lesions associated with NF1 but, instead,
represent non-neoplastic supporting cells in some tumors
and true neoplastic cells in other tumors [15].
Shaktawat and Golka recommend these cells to be
interpreted carefully, keeping in mind the rare malignant
change in neurofibromas [14]. According to Shaktawat
and Golka these are positive with vimentin and CD34
and negative with S100 and CD68 [14]. Taungjaruwinai
and Goldberg, Swick and Magro et al. described in their
cases the S100 negative FMGCs [5,13,15]. In the study
by Shaktawat and Golka the FMGCs were also negative
for the macrophage marker CD68 [14]. Multinucleated
cells have also been known as part of the spectrum of
“degenerative atypias” in neurofibromas.
The issue of possible gender predilection for FMGCs
to appear in NF1-associated neurofibromas remains un-
clear as well.
In the case presented here, FMGCs were found in a
man with NF1. Satter observed that such a constellation
may be specific for males, pointing out that all recorded
cases involved male patients [5,12-15]. Conversely, 53%
of the study cohort in the series by Magro et al. was fe-
male [11]. It is not clear, however, to what respective ex-
tent male and female patients were represented among
those 8% of patients in whom FMGCs actually were
seen [11].
In one case report, the hypothesis has been put for-
ward that trauma may trigger the emergence of FMGCs
[15]. Hypoxia and/or reparative changes were hypothe-
sized to have contributed to the induction of FMGCs
[12,15]. Therefore it remains unclear whether recur-
rence, cellular stress or injury play a role in the develop-
ment of FMGCs [12,13,16].
Furthermore, the size of the neurofibroma might also
be a stimulating factor for the appearance of FMGCs. In
our case we found a neurofibroma of 27×15cm. The lit-
erature generally describes these cells in much smaller
lesions. Taungjaruwinai and Goldberg describe FMGCs
in neurofibromas with an average size of 0.6cm [5].
Swick et al. mentioned a neurofibroma inferior to
0.8cm [15]. Magro et al. saw a neurofibroma with 10cm
diameter where they reportedly found FMGCs; whereas
Shaktawat and Golka found FMGCs in a neurofibroma
of 1.2 cm [11,13,14].Finally, surgical excision or even partial lesion reduc-
tion is indicated for alleviation of symptomatic lesions
and allows final histopathological examination [3,6,7].
Conclusion
Having discussed earlier that FMGCs are not specific
for NF1, and may appear also in other tissue, further
studies are warranted to clarify the etiopathogenesis of
FMGCs together with possible association of long-term
risk of neoplastic changes in NF1 [5,11-13]. Complete
or partial surgical removal of the lesion is indicated for
symptom alleviation and histopathological diagnosis of
the tumor [9,18].
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